Prescribing for people with acute rheumatic fever

Anna Ralph, Sara Jane Noonan, Claire Boardman, Catherine Halkon, Bart Currie

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Acute rheumatic fever and its consequence, rheumatic heart disease, remain important problems in remote indigenous Australian communities.

Aboriginal and Torres Strait Islander people living in urban settings, Maori and Pacific Islanders, and immigrants from developing countries are also likely to be at elevated risk.

Guidelines and resources are available for healthcare professionals working with at-risk populations, and for patients with acute rheumatic fever or rheumatic heart disease and their families.

There have been some recent changes in Australian recommendations for antibiotic use, dose of aspirin, first-line choice for management of severe Sydenham’s chorea, and prevention of endocarditis.

For individuals diagnosed with acute rheumatic fever, the recommended treatment to prevent recurrences and development of rheumatic heart disease is benzathine penicillin G administered as an intramuscular injection every four weeks.
Original languageEnglish
Pages (from-to)70-75
Number of pages6
JournalAustralian Prescriber
Volume40
Issue number2
DOIs
Publication statusPublished - 3 Apr 2017

Fingerprint

Rheumatic Heart Disease
Rheumatic Fever
Penicillin G Benzathine
Chorea
Intramuscular Injections
Endocarditis
Developing Countries
Aspirin
Guidelines
Anti-Bacterial Agents
Delivery of Health Care
Recurrence
Therapeutics

Cite this

Ralph, Anna ; Noonan, Sara Jane ; Boardman, Claire ; Halkon, Catherine ; Currie, Bart. / Prescribing for people with acute rheumatic fever. In: Australian Prescriber. 2017 ; Vol. 40, No. 2. pp. 70-75.
@article{ad423889f6f4496ca8631dfa49b0c2d4,
title = "Prescribing for people with acute rheumatic fever",
abstract = "Acute rheumatic fever and its consequence, rheumatic heart disease, remain important problems in remote indigenous Australian communities.Aboriginal and Torres Strait Islander people living in urban settings, Maori and Pacific Islanders, and immigrants from developing countries are also likely to be at elevated risk.Guidelines and resources are available for healthcare professionals working with at-risk populations, and for patients with acute rheumatic fever or rheumatic heart disease and their families.There have been some recent changes in Australian recommendations for antibiotic use, dose of aspirin, first-line choice for management of severe Sydenham’s chorea, and prevention of endocarditis.For individuals diagnosed with acute rheumatic fever, the recommended treatment to prevent recurrences and development of rheumatic heart disease is benzathine penicillin G administered as an intramuscular injection every four weeks.",
author = "Anna Ralph and Noonan, {Sara Jane} and Claire Boardman and Catherine Halkon and Bart Currie",
year = "2017",
month = "4",
day = "3",
doi = "10.18773/austprescr.2017.011",
language = "English",
volume = "40",
pages = "70--75",
journal = "Australian Prescriber",
issn = "0312-8008",
publisher = "National Prescribing Service",
number = "2",

}

Prescribing for people with acute rheumatic fever. / Ralph, Anna; Noonan, Sara Jane; Boardman, Claire; Halkon, Catherine; Currie, Bart.

In: Australian Prescriber, Vol. 40, No. 2, 03.04.2017, p. 70-75.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Prescribing for people with acute rheumatic fever

AU - Ralph, Anna

AU - Noonan, Sara Jane

AU - Boardman, Claire

AU - Halkon, Catherine

AU - Currie, Bart

PY - 2017/4/3

Y1 - 2017/4/3

N2 - Acute rheumatic fever and its consequence, rheumatic heart disease, remain important problems in remote indigenous Australian communities.Aboriginal and Torres Strait Islander people living in urban settings, Maori and Pacific Islanders, and immigrants from developing countries are also likely to be at elevated risk.Guidelines and resources are available for healthcare professionals working with at-risk populations, and for patients with acute rheumatic fever or rheumatic heart disease and their families.There have been some recent changes in Australian recommendations for antibiotic use, dose of aspirin, first-line choice for management of severe Sydenham’s chorea, and prevention of endocarditis.For individuals diagnosed with acute rheumatic fever, the recommended treatment to prevent recurrences and development of rheumatic heart disease is benzathine penicillin G administered as an intramuscular injection every four weeks.

AB - Acute rheumatic fever and its consequence, rheumatic heart disease, remain important problems in remote indigenous Australian communities.Aboriginal and Torres Strait Islander people living in urban settings, Maori and Pacific Islanders, and immigrants from developing countries are also likely to be at elevated risk.Guidelines and resources are available for healthcare professionals working with at-risk populations, and for patients with acute rheumatic fever or rheumatic heart disease and their families.There have been some recent changes in Australian recommendations for antibiotic use, dose of aspirin, first-line choice for management of severe Sydenham’s chorea, and prevention of endocarditis.For individuals diagnosed with acute rheumatic fever, the recommended treatment to prevent recurrences and development of rheumatic heart disease is benzathine penicillin G administered as an intramuscular injection every four weeks.

UR - http://www.scopus.com/inward/record.url?scp=85019745298&partnerID=8YFLogxK

U2 - 10.18773/austprescr.2017.011

DO - 10.18773/austprescr.2017.011

M3 - Article

VL - 40

SP - 70

EP - 75

JO - Australian Prescriber

JF - Australian Prescriber

SN - 0312-8008

IS - 2

ER -